- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mesenchymal stem cells (MSCs) as skeletal therapeutics–an update ; volume:23 ; number:1 ; day:16 ; month:4 ; year:2016 ; pages:1-15 ; date:12.2016
Journal of biomedical science ; 23, Heft 1 (16.4.2016), 1-15, 12.2016
- Urheber
-
Saeed, Hamid
- Beteiligte Personen und Organisationen
-
Aḥsan, Muḥammad
Saleem, Zikria
Iqtedar, Mehwish
Islām, Muḥammad
Danish, Zeeshan
Khan, Asif Manzoor
SpringerLink (Online service)
- DOI
-
10.1186/s12929-016-0254-3
- URN
-
urn:nbn:de:1111-201604174859
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saeed, Hamid
- Aḥsan, Muḥammad
- Saleem, Zikria
- Iqtedar, Mehwish
- Islām, Muḥammad
- Danish, Zeeshan
- Khan, Asif Manzoor
- SpringerLink (Online service)
Ähnliche Objekte (12)
Improved therapeutics of modified mesenchymal stem cells: an update
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Synthetic niche to modulate regenerative potential of MSCs and enhance skeletal muscle regeneration
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Mesenchymal and induced pluripotent stem cell–based therapeutics: a comparison
Iron-oxide-nanoparticle-tagged Mesenchymal Stem Cell Exosomes in Therapeutics
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics
Improved therapeutics of modified mesenchymal stem cells: an update
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Synthetic niche to modulate regenerative potential of MSCs and enhance skeletal muscle regeneration
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Mesenchymal and induced pluripotent stem cell–based therapeutics: a comparison
Iron-oxide-nanoparticle-tagged Mesenchymal Stem Cell Exosomes in Therapeutics
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics
Improved therapeutics of modified mesenchymal stem cells: an update
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Synthetic niche to modulate regenerative potential of MSCs and enhance skeletal muscle regeneration
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Mesenchymal and induced pluripotent stem cell–based therapeutics: a comparison
Iron-oxide-nanoparticle-tagged Mesenchymal Stem Cell Exosomes in Therapeutics
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier